rs762903007
Variant summary
Our verdict is Pathogenic. The variant received 7 ACMG points: 7P and 0B. PP4_ModeratePM3PM2_SupportingPP3_Moderate
This summary comes from the ClinGen Evidence Repository: The NM_000203.5:c.1139A>G variant in IDUA is a missense variant predicted to cause substitution of glutamine by arginine at amino acid 380 (p.Gln380Arg). This variant has been detected in at least 34 individuals with MPS I. Of those individuals, 20 were compound heterozygous for the variant and another variant in IDUA that has been classified as pathogenic or likely pathogenic variant for MPS I by the ClinGen LD VCEP, all in unknown phase. The second variant includes c.46_57del (p.Ser16_Ala19del) (PMID:35141277) (0.5 pt), c.208C>T (p.Gln70Ter)(11 patients, PMID:24368159, 24875751, 35141277) (max 2 x 0.5 points), c.979G>C p.Ala327Pro (PMID:28752568) (0.5 pt), c.1205G>A p.Trp402Ter (6 patients, PMID:28752568, 35141277) (max 2 x 0.5 pts), c.1861C>T (p.Arg621Ter) ((PMID:11735025) (0.25 pt). Four unrelated individuals are homozygous for the variant PMID:19396826, 31194252, 35141277) (max 2 x 0.5 pts). Total 4.25 points (PM3_VeryStrong). At least 19 patients with this variant had documented IDUA deficiency within the affected range in leukocytes, and/or urinary GAGs expressed as either total GAGs and/or specific GAG elevation above normal range, and/or clinical features specific to MPS I including dysostosis multiplex, corneal clouding, and hepatosplenomegaly (PP4_Moderate). The highest population minor allele frequency in gnomAD v4.10. is 0.00003112 (36/1156956 alleles) in the NFE population (gnomAD v2.1.1 is 0.00004458 with 3/67302 alleles in the NFE population), which is lower than the ClinGen Lysosomal Diseases VCEP’s threshold for PM2_Supporting (<0.00025), meeting this criterion (PM2_Supporting). The computational predictor REVEL gives a score of 0.872 which is above the threshold of 0.773, evidence that correlates with impact to IDUA function at the moderate level based on the specifications of the ClinGen Lysosomal Diseases VCEP (PMID:36413997) (PP3_Moderate). There is a ClinVar entry for this variant (Variation ID: 550799). In summary, this variant meets the criteria to be classified as Pathogenic for MPS I based on the IDUA-specific ACMG/AMP criteria applied, as specified by the ClinGen Lysosomal Diseases Variant Curation Expert panel (Specifications Version 1.0.0): PM3_Very Strong, PP3_Moderate, PP4_Moderate, PM2_Supporting.(Classification approved by the ClinGen Lysosomal Diseases Variant Curation Expert Panel on December 6, 2024) LINK:https://erepo.genome.network/evrepo/ui/classification/CA2802202/MONDO:0001586/091
Frequency
Consequence
NM_000203.5 missense
Scores
Clinical Significance
Conservation
Publications
- mucopolysaccharidosis type 1Inheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health, ClinGen
- Scheie syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
- Hurler syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
- Hurler-Scheie syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 7 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000203.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| IDUA | TSL:2 MANE Select | c.1139A>G | p.Gln380Arg | missense | Exon 8 of 14 | ENSP00000425081.2 | P35475-1 | ||
| IDUA | TSL:1 | c.1139A>G | p.Gln380Arg | missense | Exon 8 of 14 | ENSP00000247933.4 | P35475-1 | ||
| IDUA | c.1214A>G | p.Gln405Arg | missense | Exon 9 of 15 | ENSP00000632448.1 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152088Hom.: 0 Cov.: 34 show subpopulations
GnomAD2 exomes AF: 0.0000182 AC: 3AN: 165216 AF XY: 0.0000223 show subpopulations
GnomAD4 exome AF: 0.0000269 AC: 38AN: 1412116Hom.: 0 Cov.: 35 AF XY: 0.0000229 AC XY: 16AN XY: 698460 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152088Hom.: 0 Cov.: 34 AF XY: 0.00 AC XY: 0AN XY: 74300 show subpopulations
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at